MGH Thoracic Oncology
@MGHThoracicOnc
Followers
2K
Following
296
Media
36
Statuses
331
Welcome to the official Mass General Hospital Thoracic Oncology page, where research meets clinical care face to face. Follow us here for updates and more!
Boston, MA
Joined August 2019
RT @JournalCancer: Our latest edition of CancerScope: First Person Profile highlights #PalliativeCare pioneer Dr. Jennifer Temel, whose wor….
0
11
0
RT @break_cancer: Despite progress, advanced ALK+ lung cancer almost always recurs. By deeply exploring the biology of cancer cells that re….
0
6
0
RT @StephenVLiu: Dr. @IbiayiMD brings us up to speed on systemic strategies for #mesothelioma at #DCLung24. With competing immunotherapy ap….
0
2
0
RT @StephenVLiu: Dr. @JessicaJLinMD from @MGHThoracicOnc will discuss advances in targeting #ALK in advanced NSCLC at #DCLung24. Learn abou….
0
6
0
RT @StephenVLiu: Dr. @ZPiotrowskaMD from @MGHThoracicOnc will discuss #EGFR in NSCLC and overcoming resistance at #DCLung24. This is a talk….
0
3
0
Congratulations to @DrJaimeLaurel on receiving the “40 Under 40 in Cancer” award @ASCO. This achievement recognizes Dr. Schneider’s contributions to the field of cancer as one of the nation’s most promising young oncology professionals impacting lives of many affected by #cancer.
0
3
14
RT @aebchang: MGH Thoracic crew listening to not one but TWO plenary sessions by outstanding @MGHCancerCenter physicians—Dr. Joseph Greer/D….
0
4
0
RT @StephenVLiu: Dr. @LeciaSequist with a brilliant #ASCO24 discussion of LAURA and #EGFR NSCLC. Do we apply this paradigm now to subtypes….
0
31
0
RT @RManochakian: 🚨The future of #ThoracicOncology is in great hands!. My co-chair colleague Dr @ChristianRolfo, myself, great faculty ment….
0
14
0
RT @radiology_rsna: Drs. @LeciaSequist of @MGHCancerCenter and @MGHThoracicOnc and @Colazagasti of @sylvestercancer discuss the I-ELCAP stu….
pubs.rsna.org
0
8
0
RT @LaurenByersMD: Great day in Boston as a keynote speaker at the DF/HCC Lung Program Annual Symposium. Thank you for the invitation to be….
0
2
0
RT @JessicaJLinMD: Nice clearance of ALK mutations and CNS activity, and favorable safety profile! Hopeful news for patients. @alexdrilon @….
0
8
0
RT @JessicaJLinMD: Excited to share the first presentation of the preliminary activity and safety results on NVL-655, new ALK TKI. Brief re….
0
43
0
Congratulations to Dr. @DrJaimeLaurel on being invited as a Forbeck Foundation scholar to speak about systemic metabolism and #Cancer! Her #research focuses are identifying metabolic liabilities in #oncogene-driven lung cancers in hopes of developing new therapeutic strategies!.
0
1
5
Today in Nature - lung cancer targeted therapies can induce APOBEC3A, which drives evolution of acquired drug resistance. Terrific team effort led by Hata and Lawrence groups in collaboration with @ZPiotrowskaMD @LeciaSequist @JessicaJLinMD @JustinGainor.
0
26
66
RT @MGH_WiO: And now for another installment of Meet the Grads! 🩺🎓. Name: Alissa Cooper, MD (and @DanaFarber/@MassGenBrigham Chief Fellow!)….
0
9
0
RT @AmLungCSI: Our #Boston ALCSI team had a busy weekend raising #lungcancerawareness at the Mission Hill Farmer’s Market, @Whittier_Boston….
0
6
0
RT @IASLC: How do you address resistance to first-line ROS1 TKI therapy in ROS1 fusion-positive lung cancers? Tune in as @JessicaJLinMD fro….
0
5
0
RT @JessicaJLinMD: @GRecondoMD @JulienMazieres, Satoshi Yoda, many others 🌏 🙏 . This @NatureCancer review picks up from where we left off w….
0
7
0